✦ LIBER ✦

A GlycineN-methyltransferase Knockout Mouse Model for Humans with Deficiency of this Enzyme

✍ Scribed by Zigmund Luka; Antonieta Capdevila; José M. Mato; C. Wagner

Publisher: Springer Netherlands
Year: 2006
Tongue: English
Weight: 269 KB
Volume: 15
Category: Article
ISSN: 0962-8819
DOI: 10.1007/s11248-006-0008-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Characterization of a glycine N-methyltr

Characterization of a glycine N-methyltransferase gene knockout mouse model for hepatocellular carcinoma: Implications of the gender disparity in liver cancer susceptibility

✍ Yi-Jen Liao; Shih-Ping Liu; Cheng-Ming Lee; Chia-Hung Yen; Pei-Chun Chuang; Chia 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 854 KB

## Abstract Hepatocellular carcinoma (HCC) is the fifth common cancer in the world and it mainly occurs in men. Glycine __N__‐methyltransferase (GNMT) participates in one‐carbon metabolism and affects DNA methylation by regulating the ratio of __S__‐adenosylmethionine to __S__‐adenosylhomocystine.

Gene-directed enzyme prodrug therapy for

Gene-directed enzyme prodrug therapy for prostate cancer in a mouse model that imitates the development of human disease

✍ Rosetta Martiniello-Wilks; Allison Dane; Dale J. Voeks; Geetha Jeyakumar; Elin M 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB 👁 1 views

## Abstract ## Background Gene‐directed enzyme prodrug therapy (GDEPT) based on the __E. coli__ enzyme purine nucleoside phosphorylase (PNP) represents a new approach for treating slow growing tumours like prostate cancer (PCa). Expressed enzyme converts a systemically administered prodrug, fludar

Targeted replacement of rodent CCR2 with

Targeted replacement of rodent CCR2 with the human orthologue CCR2B: A mouse model for in vivo analysis of human target-selective small molecule MCP-1 receptor antagonists

✍ Haydn M. Prosser; David G. Cooper; Ian T. Forbes; Martin Geppert; Andrew D. Grib 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB 👁 1 views